Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name TAK-659
Trade Name
Drug Descriptions

TAK-659 is an inhibitor of spleen tyrosine kinase (SYK), which may lead to B-cell inhibition and antitumor activity (http://meetinglibrary.asco.org/content/134551-144).

DrugClasses SYK Inhibitor 13


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bendamustine + Rituximab + TAK-659 Bendamustine Rituximab TAK-659 0 1
Bendamustine + TAK-659 Bendamustine TAK-659 0 1
Cyclophosphamide + Doxorubicin + Prednisone + Rituximab + TAK-659 + Vincristine Cyclophosphamide Doxorubicin Prednisone Rituximab TAK-659 Vincristine 0 1
Gemcitabine + TAK-659 Gemcitabine TAK-659 0 1
Ibrutinib + TAK-659 Ibrutinib TAK-659 0 1
Ixazomib + TAK-659 Ixazomib TAK-659 0 1
Lenalidomide + TAK-659 Lenalidomide TAK-659 0 1
MLN1117 + TAK-659 MLN1117 TAK-659 0 0
Nivolumab + TAK-659 Nivolumab TAK-659 0 1
NKTR-214 + TAK-659 NKTR-214 TAK-659 0 1
Paclitaxel + TAK-659 Paclitaxel TAK-659 0 1
TAK-659 TAK-659 0 5
TAK-659 + Venetoclax TAK-659 Venetoclax 0 1

Additional content available in CKB BOOST